Amphotericin B Lipid Complex: In Visceral Leishmaniasis

Author： Goldsmith David R.   Perry Caroline M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.17, 2004-01, pp. : 1905-1911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development and Characterization of Amphotericin B Loaded Solid Lipid Nanoparticles Against Experimental Visceral Leishmaniasis

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 1, 2013-01 ,pp. : 54-67

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomal Amphotericin B: Therapeutic Use in the Management of Fungal Infections and Visceral Leishmaniasis

By Coukell A.J.   Brogden R.N.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 585-612

Adis International

Access to resources Recommend Favorite

Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis

By Gupta Swati   Dube Anuradha   Vyas Suresh P.  

Journal of Drug Targeting, Vol. 15, Iss. 6, 2007-07 ,pp. : 437-444

Informa Healthcare

Access to resources Recommend Favorite

Amphotericin B Lipid Complex: A Viewpoint by Eric Rosenthal

By Rosenthal Eric  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1912-1913

Adis International

Access to resources Recommend Favorite

Amphotericin B lipid complex best value lipid therapy in mycoses

By  

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite